ABT1 and cancer: Early work on PNAs for cancer therapy showed that anti-sense PNAs directed against the androgen receptor and TATA-binding protein genes worked by hybridization with CAG triplet repeats in LNCaP and DU-145 cell lines; no binding to c-myc, which lacks the CAG repeats was observed [24].